Title 20

PART 30

Part 30 - Claims For Compensation Under The Energy Employees Occupational Illness Compensation Program Act Of 2000, As Amended

PART 30 - CLAIMS FOR COMPENSATION UNDER THE ENERGY EMPLOYEES OCCUPATIONAL ILLNESS COMPENSATION PROGRAM ACT OF 2000, AS AMENDED Authority:5 U.S.C. 301; 31 U.S.C. 3716 and 3717; 42 U.S.C. 7384d, 7384t, 7384u and 7385s-10; Executive Order 13179, 65 FR 77487, 3 CFR, 2000 Comp., p. 321; Secretary of Labor's Order No. 10-2009, 74 FR 58834. Source:71 FR 78534, Dec. 29, 2006, unless otherwise noted.

20:1.0.1.3.4.1SUBPART A
Subpart A - General Provisions
20:1.0.1.3.4.1.116SUBJGRP 116
   Introduction
20:1.0.1.3.4.1.116.1SECTION 30.0
   30.0 What are the provisions of EEOICPA, in general
20:1.0.1.3.4.1.116.2SECTION 30.1
   30.1 What rules govern the administration of EEOICPA and this chapter
20:1.0.1.3.4.1.116.3SECTION 30.2
   30.2 In general, how have the tasks associated with the administration of EEOICPA claims process been assigned
20:1.0.1.3.4.1.116.4SECTION 30.3
   30.3 What do these regulations contain
20:1.0.1.3.4.1.117SUBJGRP 117
   Definitions
20:1.0.1.3.4.1.117.5SECTION 30.5
   30.5 What are the definitions used in this part
20:1.0.1.3.4.1.118SUBJGRP 118
   Information in Program Records
20:1.0.1.3.4.1.118.6SECTION 30.10
   30.10 Are all OWCP records relating to claims filed under EEOICPA considered confidential
20:1.0.1.3.4.1.118.7SECTION 30.11
   30.11 Who maintains custody and control of claim records
20:1.0.1.3.4.1.118.8SECTION 30.12
   30.12 What process is used by a person who wants to obtain copies of or amend EEOICPA claim records
20:1.0.1.3.4.1.119SUBJGRP 119
   Rights and Penalties
20:1.0.1.3.4.1.119.9SECTION 30.15
   30.15 May EEOICPA benefits be assigned, transferred or garnished
20:1.0.1.3.4.1.119.10SECTION 30.16
   30.16 What penalties may be imposed in connection with a claim under the Act
20:1.0.1.3.4.1.119.11SECTION 30.17
   30.17 Is a beneficiary who defrauds the government in connection with a claim for EEOICPA benefits still entitled to those benefits
20:1.0.1.3.4.2SUBPART B
Subpart B - Filing Claims; Evidence and Burden of Proof; Special Procedures for Certain Cancer Claims
20:1.0.1.3.4.2.120SUBJGRP 120
   Filing Claims for Benefits Under EEOICPA
20:1.0.1.3.4.2.120.1SECTION 30.100
   30.100 In general, how does an employee file an initial claim for benefits
20:1.0.1.3.4.2.120.2SECTION 30.101
   30.101 In general, how is a survivor's claim filed
20:1.0.1.3.4.2.120.3SECTION 30.102
   30.102 In general, how does an employee file a claim for additional impairment or wage-loss under Part E of EEOICPA
20:1.0.1.3.4.2.120.4SECTION 30.103
   30.103 How does a claimant make sure that OWCP has the evidence necessary to process the claim
20:1.0.1.3.4.2.121SUBJGRP 121
   Verification of Alleged Employment
20:1.0.1.3.4.2.121.5SECTION 30.105
   30.105 What must DOE do after an employee or survivor files a claim
20:1.0.1.3.4.2.121.6SECTION 30.106
   30.106 Can OWCP request employment verification from other sources
20:1.0.1.3.4.2.122SUBJGRP 122
   Evidence and Burden of Proof
20:1.0.1.3.4.2.122.7SECTION 30.110
   30.110 Who is entitled to compensation under the Act
20:1.0.1.3.4.2.122.8SECTION 30.111
   30.111 What is the claimant's responsibility with respect to burden of proof, production of documents, presumptions, and affidavits
20:1.0.1.3.4.2.122.9SECTION 30.112
   30.112 What kind of evidence is needed to establish covered employment and how will that evidence be evaluated
20:1.0.1.3.4.2.122.10SECTION 30.113
   30.113 What are the requirements for written medical documentation, contemporaneous records, and other records or documents
20:1.0.1.3.4.2.122.11SECTION 30.114
   30.114 What kind of evidence is needed to establish a compensable medical condition and how will that evidence be evaluated
20:1.0.1.3.4.2.123SUBJGRP 123
   Special Procedures for Certain Radiogenic Cancer Claims
20:1.0.1.3.4.2.123.12SECTION 30.115
   30.115 For those radiogenic cancer claims that do not seek benefits under Part B of the Act pursuant to the Special Exposure Cohort provisions, what will OWCP do once it determines that an employee contracted cancer
20:1.0.1.3.4.3SUBPART C
Subpart C - Eligibility Criteria
20:1.0.1.3.4.3.124SUBJGRP 124
   General Provisions
20:1.0.1.3.4.3.124.1SECTION 30.200
   30.200 What is the scope of this subpart
20:1.0.1.3.4.3.125SUBJGRP 125
   Eligibility Criteria for Claims Relating to Covered Beryllium Illness Under Part B of EEOICPA
20:1.0.1.3.4.3.125.2SECTION 30.205
   30.205 What are the criteria for eligibility for benefits relating to beryllium illnesses covered under Part B of EEOICPA
20:1.0.1.3.4.3.125.3SECTION 30.206
   30.206 How does a claimant prove that the employee was a “covered beryllium employee” exposed to beryllium dust, particles or vapor in the performance of duty
20:1.0.1.3.4.3.125.4SECTION 30.207
   30.207 How does a claimant prove a diagnosis of a beryllium disease covered under Part B
20:1.0.1.3.4.3.126SUBJGRP 126
   Eligibility Criteria for Claims Relating to Radiogenic Cancer Under Parts B and E of EEOICPA
20:1.0.1.3.4.3.126.5SECTION 30.210
   30.210 What are the criteria for eligibility for benefits relating to radiogenic cancer
20:1.0.1.3.4.3.126.6SECTION 30.211
   30.211 How does a claimant establish that the employee has or had contracted cancer
20:1.0.1.3.4.3.126.7SECTION 30.212
   30.212 How does a claimant establish that the employee contracted cancer after beginning employment at a DOE facility, an atomic weapons employer facility or a RECA section 5 facility
20:1.0.1.3.4.3.126.8SECTION 30.213
   30.213 How does a claimant establish that the radiogenic cancer was at least as likely as not related to employment at the DOE facility, the atomic weapons employer facility, or the RECA section 5 facility
20:1.0.1.3.4.3.126.9SECTION 30.214
   30.214 How does a claimant establish that the employee is a member of the Special Exposure Cohort
20:1.0.1.3.4.3.126.10SECTION 30.215
   30.215 How does a claimant establish that the employee has sustained an injury, illness, impairment or disease as a consequence of a diagnosed cancer
20:1.0.1.3.4.3.127SUBJGRP 127
   Eligibility Criteria for Claims Relating to Chronic Silicosis Under Part B of EEOICPA
20:1.0.1.3.4.3.127.11SECTION 30.220
   30.220 What are the criteria for eligibility for benefits relating to chronic silicosis
20:1.0.1.3.4.3.127.12SECTION 30.221
   30.221 How does a claimant prove exposure to silica in the performance of duty
20:1.0.1.3.4.3.127.13SECTION 30.222
   30.222 How does a claimant establish that the employee has been diagnosed with chronic silicosis or has sustained a consequential injury, illness, impairment or disease
20:1.0.1.3.4.3.128SUBJGRP 128
   Eligibility Criteria for Certain Uranium Employees Under Part B of EEOICPA
20:1.0.1.3.4.3.128.14SECTION 30.225
   30.225 What are the criteria for eligibility for benefits under Part B of EEOICPA for certain uranium employees
20:1.0.1.3.4.3.128.15SECTION 30.226
   30.226 How does a claimant establish that a covered uranium employee has sustained a consequential injury, illness, impairment or disease
20:1.0.1.3.4.3.129SUBJGRP 129
   Eligibility Criteria for Other Claims Under Part E of EEOICPA
20:1.0.1.3.4.3.129.16SECTION 30.230
   30.230 What are the criteria necessary to establish that an employee contracted a covered illness under Part E of EEOICPA
20:1.0.1.3.4.3.129.17SECTION 30.231
   30.231 How does a claimant prove employment-related exposure to a toxic substance at a DOE facility or a RECA section 5 facility
20:1.0.1.3.4.3.129.18SECTION 30.232
   30.232 How does a claimant establish that the employee has been diagnosed with a covered illness, or sustained an injury, illness, impairment or disease as a consequence of a covered illness
20:1.0.1.3.4.4SUBPART D
Subpart D - Adjudicatory Process
20:1.0.1.3.4.4.130SUBJGRP 130
   General Provisions
20:1.0.1.3.4.4.130.1SECTION 30.300
   30.300 What administrative process will OWCP use to decide claims for entitlement, and how can claimants obtain judicial review of final decisions on their claims
20:1.0.1.3.4.4.130.2SECTION 30.301
   30.301 May subpoenas be issued for witnesses and documents in connection with a claim under Part B of EEOICPA
20:1.0.1.3.4.4.130.3SECTION 30.302
   30.302 Who pays the costs associated with subpoenas
20:1.0.1.3.4.4.130.4SECTION 30.303
   30.303 What information may OWCP request in connection with a claim under Part E of EEOICPA
20:1.0.1.3.4.4.131SUBJGRP 131
   Recommended Decisions on Claims
20:1.0.1.3.4.4.131.5SECTION 30.305
   30.305 How does OWCP determine entitlement to EEOICPA compensation
20:1.0.1.3.4.4.131.6SECTION 30.306
   30.306 What does the recommended decision include
20:1.0.1.3.4.4.131.7SECTION 30.307
   30.307 Can one recommended decision address the entitlement of multiple claimants
20:1.0.1.3.4.4.131.8SECTION 30.308
   30.308 To whom is the recommended decision sent
20:1.0.1.3.4.4.132SUBJGRP 132
   Hearings and Final Decisions on Claims
20:1.0.1.3.4.4.132.9SECTION 30.310
   30.310 What must the claimant do if he or she objects to the recommended decision or wants to request a hearing
20:1.0.1.3.4.4.132.10SECTION 30.311
   30.311 What happens if the claimant does not object to the recommended decision or request a hearing within 60 days
20:1.0.1.3.4.4.132.11SECTION 30.312
   30.312 What will the FAB do if the claimant objects to the recommended decision but does not request a hearing
20:1.0.1.3.4.4.132.12SECTION 30.313
   30.313 How is a review of the written record conducted
20:1.0.1.3.4.4.132.13SECTION 30.314
   30.314 How is a hearing conducted
20:1.0.1.3.4.4.132.14SECTION 30.315
   30.315 May a claimant postpone a hearing
20:1.0.1.3.4.4.132.15SECTION 30.316
   30.316 How does the FAB issue a final decision on a claim
20:1.0.1.3.4.4.132.16SECTION 30.317
   30.317 Can the FAB request a further response from the claimant or return a claim to the district office
20:1.0.1.3.4.4.132.17SECTION 30.318
   30.318 How will FAB consider objections to NIOSH's reconstruction of a radiation dose, or to OWCP's calculation of the recommended probability of causation, in a Part B claim for radiogenic cancer
20:1.0.1.3.4.4.132.18SECTION 30.319
   30.319 May a claimant request reconsideration of a final decision of the FAB
20:1.0.1.3.4.4.133SUBJGRP 133
   Reopening Claims
20:1.0.1.3.4.4.133.19SECTION 30.320
   30.320 Can a claim be reopened after the FAB has issued a final decision
20:1.0.1.3.4.5SUBPART E
Subpart E - Medical and Related Benefits
20:1.0.1.3.4.5.134SUBJGRP 134
   Medical Treatment and Related Issues
20:1.0.1.3.4.5.134.1SECTION 30.400
   30.400 What are the basic rules for obtaining medical treatment
20:1.0.1.3.4.5.134.2SECTION 30.401
   30.401 What are the special rules for the services of chiropractors
20:1.0.1.3.4.5.134.3SECTION 30.402
   30.402 What are the special rules for the services of clinical psychologists
20:1.0.1.3.4.5.134.4SECTION 30.403
   30.403 Will OWCP pay for home health care, nursing home, and assisted living services
20:1.0.1.3.4.5.134.5SECTION 30.404
   30.404 Will OWCP pay for transportation to obtain medical treatment
20:1.0.1.3.4.5.134.6SECTION 30.405
   30.405 After selecting a treating physician, may an employee choose to be treated by another physician instead
20:1.0.1.3.4.5.134.7SECTION 30.406
   30.406 Are there any exceptions to these procedures for obtaining medical care
20:1.0.1.3.4.5.135SUBJGRP 135
   Directed Medical Examinations
20:1.0.1.3.4.5.135.8SECTION 30.410
   30.410 Can OWCP require an employee to be examined by another physician
20:1.0.1.3.4.5.135.9SECTION 30.411
   30.411 What happens if the opinion of the physician selected by OWCP differs from the opinion of the physician selected by the employee
20:1.0.1.3.4.5.135.10SECTION 30.412
   30.412 Who pays for second opinion and referee examinations
20:1.0.1.3.4.5.136SUBJGRP 136
   Medical Reports
20:1.0.1.3.4.5.136.11SECTION 30.415
   30.415 What are the requirements for medical reports
20:1.0.1.3.4.5.136.12SECTION 30.416
   30.416 How and when should medical reports be submitted
20:1.0.1.3.4.5.136.13SECTION 30.417
   30.417 What additional medical information may OWCP require to support continuing payment of benefits
20:1.0.1.3.4.5.137SUBJGRP 137
   Medical Bills
20:1.0.1.3.4.5.137.14SECTION 30.420
   30.420 How should medical bills and reimbursement requests be submitted
20:1.0.1.3.4.5.137.15SECTION 30.421
   30.421 What are the time frames for submitting bills and reimbursement requests
20:1.0.1.3.4.5.137.16SECTION 30.422
   30.422 If an employee is only partially reimbursed for a medical expense, must the provider refund the balance of the amount paid to the employee
20:1.0.1.3.4.6SUBPART F
Subpart F - Survivors; Payments and Offsets; Overpayments
20:1.0.1.3.4.6.138SUBJGRP 138
   Survivors
20:1.0.1.3.4.6.138.1SECTION 30.500
   30.500 What special statutory definitions apply to survivors under EEOICPA
20:1.0.1.3.4.6.138.2SECTION 30.501
   30.501 What order of precedence will OWCP use to determine which survivors are entitled to receive compensation under EEOICPA
20:1.0.1.3.4.6.138.3SECTION 30.502
   30.502 When is entitlement for survivors determined for purposes of EEOICPA
20:1.0.1.3.4.6.139SUBJGRP 139
   Payment of Claims and Offset for Certain Payments
20:1.0.1.3.4.6.139.4SECTION 30.505
   30.505 What procedures will OWCP follow before it pays any compensation
20:1.0.1.3.4.6.139.5SECTION 30.506
   30.506 To whom and in what manner will OWCP pay compensation
20:1.0.1.3.4.6.139.6SECTION 30.507
   30.507 What compensation will be provided to covered Part B employees who only establish beryllium sensitivity under Part B of EEOICPA
20:1.0.1.3.4.6.139.7SECTION 30.508
   30.508 What is beryllium sensitivity monitoring
20:1.0.1.3.4.6.139.8SECTION 30.509
   30.509 Under what circumstances may a survivor claiming under Part E of the Act choose to receive the benefits that would otherwise be payable to a covered Part E employee who is deceased
20:1.0.1.3.4.6.140SUBJGRP 140
   Overpayments
20:1.0.1.3.4.6.140.9SECTION 30.510
   30.510 How does OWCP notify an individual of a payment made on a claim
20:1.0.1.3.4.6.140.10SECTION 30.511
   30.511 What is an “overpayment” for purposes of EEOICPA
20:1.0.1.3.4.6.140.11SECTION 30.512
   30.512 What does OWCP do when an overpayment is identified
20:1.0.1.3.4.6.140.12SECTION 30.513
   30.513 Under what circumstances may OWCP waive recovery of an overpayment
20:1.0.1.3.4.6.140.13SECTION 30.514
   30.514 If OWCP finds that the recipient of an overpayment was not at fault, what criteria are used to decide whether to waive recovery of it
20:1.0.1.3.4.6.140.14SECTION 30.515
   30.515 Is a recipient responsible for an overpayment that resulted from an error made by OWCP
20:1.0.1.3.4.6.140.15SECTION 30.516
   30.516 Under what circumstances would recovery of an overpayment defeat the purpose of the Act
20:1.0.1.3.4.6.140.16SECTION 30.517
   30.517 Under what circumstances would recovery of an overpayment be against equity and good conscience
20:1.0.1.3.4.6.140.17SECTION 30.518
   30.518 Can OWCP require the recipient of the overpayment to submit additional financial information
20:1.0.1.3.4.6.140.18SECTION 30.519
   30.519 How does OWCP communicate its final decision concerning recovery of an overpayment
20:1.0.1.3.4.6.140.19SECTION 30.520
   30.520 How are overpayments collected
20:1.0.1.3.4.7SUBPART G
Subpart G - Special Provisions
20:1.0.1.3.4.7.141SUBJGRP 141
   Representation
20:1.0.1.3.4.7.141.1SECTION 30.600
   30.600 May a claimant designate a representative
20:1.0.1.3.4.7.141.2SECTION 30.601
   30.601 Who may serve as a representative
20:1.0.1.3.4.7.141.3SECTION 30.602
   30.602 Who is responsible for paying the representative's fee
20:1.0.1.3.4.7.141.4SECTION 30.603
   30.603 Are there any limitations on what the representative may charge the claimant for his or her services
20:1.0.1.3.4.7.142SUBJGRP 142
   Third Party Liability
20:1.0.1.3.4.7.142.5SECTION 30.605
   30.605 What rights does the United States have upon payment of compensation under EEOICPA
20:1.0.1.3.4.7.142.6SECTION 30.606
   30.606 Under what circumstances must a recovery of money or other property in connection with an illness for which benefits are payable under EEOICPA be reported to OWCP
20:1.0.1.3.4.7.142.7SECTION 30.607
   30.607 How is a structured settlement (that is, a settlement providing for receipt of funds over a specified period of time) treated for purposes of reporting the recovery
20:1.0.1.3.4.7.142.8SECTION 30.608
   30.608 How does the United States calculate the amount to which it is subrogated
20:1.0.1.3.4.7.142.9SECTION 30.609
   30.609 Is a settlement or judgment received as a result of allegations of medical malpractice in treating an illness covered by EEOICPA a recovery that must be reported to OWCP
20:1.0.1.3.4.7.142.10SECTION 30.610
   30.610 Are payments to a covered Part B employee, a covered Part E employee or an eligible surviving beneficiary as a result of an insurance policy which the employee or eligible surviving beneficiary has purchased a recovery that must be reported to OWCP
20:1.0.1.3.4.7.142.11SECTION 30.611
   30.611 If a settlement or judgment is received for more than one medical condition, can the amount paid on a single EEOICPA claim be attributed to different conditions for purposes of calculating the amount to which the United States is subrogated
20:1.0.1.3.4.7.143SUBJGRP 143
   Effect of Tort Suits Against Beryllium Vendors and Atomic Weapons Employers
20:1.0.1.3.4.7.143.12SECTION 30.615
   30.615 What type of tort suits filed against beryllium vendors or atomic weapons employers may disqualify certain claimants from receiving benefits under Part B of EEOICPA
20:1.0.1.3.4.7.143.13SECTION 30.616
   30.616 What happens if this type of tort suit was filed prior to October 30, 2000
20:1.0.1.3.4.7.143.14SECTION 30.617
   30.617 What happens if this type of tort suit was filed during the period from October 30, 2000 through December 28, 2001
20:1.0.1.3.4.7.143.15SECTION 30.618
   30.618 What happens if this type of tort suit was filed after December 28, 2001
20:1.0.1.3.4.7.143.16SECTION 30.619
   30.619 Do all the parties to this type of tort suit have to take these actions
20:1.0.1.3.4.7.143.17SECTION 30.620
   30.620 How will OWCP ascertain whether a claimant filed this type of tort suit and if he or she has been disqualified from receiving any benefits under Part B of EEOICPA
20:1.0.1.3.4.7.144SUBJGRP 144
   Coordination of Part E Benefits With State Workers' Compensation Benefits
20:1.0.1.3.4.7.144.18SECTION 30.625
   30.625 What does “coordination of benefits” mean under Part E of EEOICPA
20:1.0.1.3.4.7.144.19SECTION 30.626
   30.626 How will OWCP coordinate compensation payable under Part E of EEOICPA with benefits from state workers' compensation programs
20:1.0.1.3.4.7.144.20SECTION 30.627
   30.627 Under what circumstances will OWCP waive the statutory requirement to coordinate these benefits
20:1.0.1.3.4.8SUBPART H
Subpart H - Information for Medical Providers
20:1.0.1.3.4.8.145SUBJGRP 145
   Medical Records and Bills
20:1.0.1.3.4.8.145.1SECTION 30.700
   30.700 In general, what responsibilities do providers have with respect to enrolling with OWCP, seeking authorization to provide services, billing, and retaining medical records
20:1.0.1.3.4.8.145.2SECTION 30.701
   30.701 How are medical bills to be submitted
20:1.0.1.3.4.8.145.3SECTION 30.702
   30.702 How should an employee prepare and submit requests for reimbursement for medical expenses, transportation costs, loss of wages, and incidental expenses
20:1.0.1.3.4.8.145.4SECTION 30.703
   30.703 What are the time limitations on OWCP's payment of bills
20:1.0.1.3.4.8.146SUBJGRP 146
   Medical Fee Schedule
20:1.0.1.3.4.8.146.5SECTION 30.705
   30.705 What services are covered by the OWCP fee schedule
20:1.0.1.3.4.8.146.6SECTION 30.706
   30.706 How are the maximum fees for professional medical services defined
20:1.0.1.3.4.8.146.7SECTION 30.707
   30.707 How are payments to providers calculated
20:1.0.1.3.4.8.146.8SECTION 30.708
   30.708 Does the fee schedule apply to every kind of procedure
20:1.0.1.3.4.8.146.9SECTION 30.709
   30.709 How are payments for medicinal drugs determined
20:1.0.1.3.4.8.146.10SECTION 30.710
   30.710 How are payments for inpatient medical services determined
20:1.0.1.3.4.8.146.11SECTION 30.711
   30.711 How are payments for outpatient medical services determined
20:1.0.1.3.4.8.146.12SECTION 30.712
   30.712 When and how are fees reduced
20:1.0.1.3.4.8.146.13SECTION 30.713
   30.713 If OWCP reduces a fee, may a provider request reconsideration of the reduction
20:1.0.1.3.4.8.146.14SECTION 30.714
   30.714 If OWCP reduces a fee, may a provider bill the employee for the balance
20:1.0.1.3.4.8.147SUBJGRP 147
   Exclusion of Providers
20:1.0.1.3.4.8.147.15SECTION 30.715
   30.715 What are the grounds for excluding a provider from payment under this part
20:1.0.1.3.4.8.147.16SECTION 30.716
   30.716 What will cause OWCP to automatically exclude a physician or other provider of medical services and supplies
20:1.0.1.3.4.8.147.17SECTION 30.717
   30.717 When are OWCP's exclusion procedures initiated
20:1.0.1.3.4.8.147.18SECTION 30.718
   30.718 How is a provider notified of OWCP's intent to exclude him or her
20:1.0.1.3.4.8.147.19SECTION 30.719
   30.719 What requirements must the provider's response and OWCP's decision meet
20:1.0.1.3.4.8.147.20SECTION 30.720
   30.720 How can an excluded provider request a hearing
20:1.0.1.3.4.8.147.21SECTION 30.721
   30.721 How are hearings assigned and scheduled
20:1.0.1.3.4.8.147.22SECTION 30.722
   30.722 How are subpoenas or advisory opinions obtained
20:1.0.1.3.4.8.147.23SECTION 30.723
   30.723 How will the administrative law judge conduct the hearing and issue the recommended decision
20:1.0.1.3.4.8.147.24SECTION 30.724
   30.724 How does a recommended decision become final
20:1.0.1.3.4.8.147.25SECTION 30.725
   30.725 What are the effects of non-automatic exclusion
20:1.0.1.3.4.8.147.26SECTION 30.726
   30.726 How can an excluded provider be reinstated
20:1.0.1.3.4.9SUBPART I
Subpart I - Wage-Loss Determinations Under Part E of EEOICPA
20:1.0.1.3.4.9.148SUBJGRP 148
   General Provisions
20:1.0.1.3.4.9.148.1SECTION 30.800
   30.800 What types of wage-loss are compensable under Part E of EEOICPA
20:1.0.1.3.4.9.148.2SECTION 30.801
   30.801 What special definitions does OWCP use in connection with Part E wage-loss determinations
20:1.0.1.3.4.9.149SUBJGRP 149
   Evidence of Wage-Loss
20:1.0.1.3.4.9.149.3SECTION 30.805
   30.805 What are the criteria for eligibility for wage-loss benefits under Part E
20:1.0.1.3.4.9.149.4SECTION 30.806
   30.806 What kind of medical evidence must the claimant submit to prove that he or she lost wages due to a covered illness
20:1.0.1.3.4.9.149.5SECTION 30.807
   30.807 What factual evidence does OWCP use to determine a covered Part E employee's average annual wage
20:1.0.1.3.4.9.150SUBJGRP 150
   Determinations of Average Annual Wage and Percentages of Loss
20:1.0.1.3.4.9.150.6SECTION 30.810
   30.810 How will OWCP calculate the average annual wage of a covered Part E employee
20:1.0.1.3.4.9.150.7SECTION 30.811
   30.811 How will OWCP calculate the duration and extent of a covered Part E employee's initial period of compensable wage-loss
20:1.0.1.3.4.9.150.8SECTION 30.812
   30.812 May a covered Part E employee claim for subsequent periods of compensable wage-loss
20:1.0.1.3.4.9.151SUBJGRP 151
   Special Rules for Certain Survivor Claims Under Part E of EEOICPA
20:1.0.1.3.4.9.151.9SECTION 30.815
   30.815 Are there special rules that OWCP will use to determine the extent of a deceased covered Part E employee's compensable wage-loss
20:1.0.1.3.4.10SUBPART J
Subpart J - Impairment Benefits Under Part E of EEOICPA
20:1.0.1.3.4.10.152SUBJGRP 152
   General Provisions
20:1.0.1.3.4.10.152.1SECTION 30.900
   30.900 Who can receive impairment benefits under Part E
20:1.0.1.3.4.10.152.2SECTION 30.901
   30.901 How does OWCP determine the extent of an employee's impairment that is due to a covered illness contracted through exposure to a toxic substance at a DOE facility or a RECA section 5 facility, as appropriate
20:1.0.1.3.4.10.152.3SECTION 30.902
   30.902 How will OWCP calculate the amount of the award of impairment benefits that is payable under Part E
20:1.0.1.3.4.10.153SUBJGRP 153
   Medical Evidence of Impairment
20:1.0.1.3.4.10.153.4SECTION 30.905
   30.905 How may an impairment evaluation be obtained
20:1.0.1.3.4.10.153.5SECTION 30.906
   30.906 Who will pay for an impairment evaluation
20:1.0.1.3.4.10.153.6SECTION 30.907
   30.907 Can an impairment evaluation obtained by OWCP be challenged prior to issuance of the recommended decision
20:1.0.1.3.4.10.153.7SECTION 30.908
   30.908 How will the FAB evaluate new medical evidence submitted to challenge the impairment determination in the recommended decision
20:1.0.1.3.4.10.154SUBJGRP 154
   Ratable Impairments
20:1.0.1.3.4.10.154.8SECTION 30.910
   30.910 Will an impairment that cannot be assigned a numerical percentage using the AMA's Guides be included in the impairment rating
20:1.0.1.3.4.10.154.9SECTION 30.911
   30.911 Does maximum medical improvement always have to be reached for an impairment to be included in the impairment rating
20:1.0.1.3.4.10.154.10SECTION 30.912
   30.912 Can a covered Part E employee receive benefits for additional impairment following an award of such benefits by OWCP